Home Icon
Ha Noi CPC1 Pharmaceutical JSCLeading Pharmaceutical Technology
(+84) 98 440 46 50
English

Uformat

Ảnh sản phẩm

Active Element: Urosodeoxycholic acid

Dosage Form:

Composition

Urosodeoxycholic acid

Dosage Form

Oral suspension

Indication

indicated in the treatment of primary biliary cholangitis (PBC) and for the dissolution of radiolucent gallstones in patients with a functioning gall bladder

Paediatric population

Hepatobiliary disorders associated with cystic fibrosis in children aged 1 month to 18 years.


Dosage Adminstration

The daily dose depends on body weight, and is approximately 14 ± 2 mg UDCA per kg of body weight.

Related Products

Ha Noi CPC1 Pharmaceutical JSC
Contact Us
Ha Noi CPC1 Pharmaceutical JSCHa Binh Phuong Industrial Zone, Thuong Tin District, Hanoi, VietnamWhatsApp/Viber/Mobile: (+84) 98 440 46 50
FacebookLinkedinTrustPass
Copyright © CPC1HN 2024